A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...

Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today reported financial ...